Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression
- PMID: 25624912
- PMCID: PMC4301531
- DOI: 10.3892/ol.2014.2795
Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression
Abstract
Malignant spinal cord compression (MSCC) is a common complication of cancer. Paraspinal neuroblastoma (NB) in the thoracic, abdominal and pelvic regions may extend into the neural foramina causing compression of nerve roots and even the spinal cord. The prompt initiation of specific treatment can improve the neurological outcome. The aim of the present study was to review the clinical features, the management received and the factors that may affect the outcome of patients with MSCC caused by paraspinal NB. During a period between July 2007 and December 2012, a total of 576 NB patients were treated at the Children's Cancer Hospital (Cairo, Egypt). Intraspinal disease extension was present in 51 patients (9%). The children with intraspinal disease extension were reviewed for disease pattern, neurological manifestations and treatment outcome. Children with intraspinal disease extension had an equal male to female ratio (1:1), and approximately two-thirds of patients (34/51) had a clinically manifested cord compression. The duration of neurological manifestations was >4 weeks in 58.8% (20/34) of symptomatic patients and ≤4 weeks in 41.2% (14/34). Subsequent to starting treatment, neurological manifestations showed a complete recovery in 16 patients (47.1%), partial in 11 (32.4%), and stationary course was found in 7 (20.6%). Manifestations of ≤4 weeks in duration carried an improved outcome compared with longer time compression, with a complete recovery in 78.6%, versus 25% for patients with a longer symptom duration (P=0.008). The upfront treatment, patient age and site of the primary tumor did not significantly affect the neurological outcome. Spinal cord compression in NB can be effectively managed with upfront chemotherapy. Initial surgical decompression should be reserved for benign variants only, including ganglioneuroma. Neurological manifestations of <4 weeks duration upon presentation are usually reversible.
Keywords: cord compression; intraspinal; neuroblastoma; outcome; treatment.
Similar articles
-
Clinical characteristics and therapeutic outcomes of mediastinal neuroblastoma with intraspinal extension: a retrospective study.Transl Pediatr. 2021 Apr;10(4):715-722. doi: 10.21037/tp-20-268. Transl Pediatr. 2021. PMID: 34012821 Free PMC article.
-
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531.Pediatr Blood Cancer. 2025 Jan;72(1):e31407. doi: 10.1002/pbc.31407. Epub 2024 Nov 6. Pediatr Blood Cancer. 2025. PMID: 39502014
-
Long-term outcome of patients with intraspinal neuroblastoma.Med Pediatr Oncol. 1999 May;32(5):353-9. doi: 10.1002/(sici)1096-911x(199905)32:5<353::aid-mpo8>3.0.co;2-2. Med Pediatr Oncol. 1999. PMID: 10219337
-
A case of congenital intraspinal neuroblastoma.J Pediatr Surg. 1997 Sep;32(9):1371-6. doi: 10.1016/s0022-3468(97)90326-2. J Pediatr Surg. 1997. PMID: 9314267 Review.
-
[Vertebral hemangioma of the posterior arch with subsequent extraosseous extension and neurological symptoms. Case report and literature review].Cir Cir. 2009 Mar-Apr;77(2):127-30. Cir Cir. 2009. PMID: 19534864 Review. Spanish.
Cited by
-
Age at Diagnosis and Baseline Myelomalacia Sign Predict Functional Outcome After Spinal Meningioma Surgery.Front Surg. 2021 Jul 2;8:682930. doi: 10.3389/fsurg.2021.682930. eCollection 2021. Front Surg. 2021. PMID: 34277695 Free PMC article.
-
Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN).Front Pediatr. 2022 Oct 10;10:1023498. doi: 10.3389/fped.2022.1023498. eCollection 2022. Front Pediatr. 2022. PMID: 36299690 Free PMC article.
-
Late effects and survival of children with malignant solid tumours in northern Finland: a single-centre cohort study.Eur J Pediatr. 2022 Jun;181(6):2263-2272. doi: 10.1007/s00431-022-04399-7. Epub 2022 Feb 24. Eur J Pediatr. 2022. PMID: 35199241 Free PMC article.
-
Clinical characteristics and therapeutic outcomes of mediastinal neuroblastoma with intraspinal extension: a retrospective study.Transl Pediatr. 2021 Apr;10(4):715-722. doi: 10.21037/tp-20-268. Transl Pediatr. 2021. PMID: 34012821 Free PMC article.
-
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531.Pediatr Blood Cancer. 2025 Jan;72(1):e31407. doi: 10.1002/pbc.31407. Epub 2024 Nov 6. Pediatr Blood Cancer. 2025. PMID: 39502014
References
-
- Brodeur GM, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 5th edition. JB Lippincott Company; Philadelphia, PA: 2006. pp. 933–970.
-
- De Bernardi B, Pianca C, Pistamiglio P, et al. Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases. J Clin Oncol. 2001;19:183–190. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources